Ablation has gained immense popularity all over the world as it offers minimally invasive solutions for the removal of tissues or tumors with bearable pain, and a lesser recovery period compared to open surgical procedures. Demand for ablation devices is expected to increase owing to increasing incidence of chronic diseases, mainly tumorigenic cancer and other cardiovascular disorders, across the globe. Chronic diseases are the major cause of mortality which resulted in over 38 million deaths worldwide in 2015, according to the World Health Organization (WHO).
Restraints of the Global Radiofrequency Ablation Devices Market for Pain Management
Major factors hampering the growth of the radiofrequency ablation devices market for pain management during the forecast period constitutes of high costs, and low awareness of ablation technique.
Key features of the study:
Detailed Segmentation
Global Radiofrequency Ablation Devices Market for Pain Management, By Product:
Global Radiofrequency Ablation Devices Market for Pain Management, By End User:
Global Radiofrequency Ablation Devices Market for Pain Management, By Geography:
By Country:
By Country:
By Country:
By Country:
o Middle East:
By Country:
By Country/Region:
“*” marked represents similar segmentation in other categories in the respective section.
Restraints of the Global Radiofrequency Ablation Devices Market for Pain Management
Major factors hampering the growth of the radiofrequency ablation devices market for pain management during the forecast period constitutes of high costs, and low awareness of ablation technique.
Key features of the study:
- This report provides in-depth analysis of the global radiofrequency ablation devices market for pain management and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global radiofrequency ablation devices market for pain management based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Accuray, Inc., Avanos Medical, Inc., Boston Scientific Corporation, Biosense Webster, Inc., Cosman Medical, Inc., Diros Technology, Inc., Kimberly-Clark Corporation, NeuroTherm, Inc., St. Jude Medical, Inc., and Stryker Corporation.
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global radiofrequency ablation devices market for pain management report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Radiofrequency Ablation Devices Market for Pain Management, By Product:
- Equipment
- Reusables
- Probes
- Electrodes
- Disposables
- Cannulas
- Needles
- RF- Single Use Probe
- RF- Single Use Electrodes
Global Radiofrequency Ablation Devices Market for Pain Management, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
Global Radiofrequency Ablation Devices Market for Pain Management, By Geography:
- North America
By Country:
- U.S.
- Canada
- Europe
By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
o Middle East:
By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
By Country/Region:
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Accuray, Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Avanos Medical, Inc.
- Boston Scientific Corporation
- Biosense Webster, Inc.
- Cosman Medical, Inc.
- Diros Technology, Inc.
- Kimberly-Clark Corporation
- NeuroTherm, Inc.
- St. Jude Medical, Inc.
- Stryker Corporation
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Radiofrequency Ablation Devices Market for Pain Management, By Product, 2016 - 2027 (US$ Mn)
5. Global Radiofrequency Ablation Devices Market for Pain Management, By End User, 2016 - 2027 (US$ Mn)
6. Global Radiofrequency Ablation Devices Market for Pain Management, By Regions, 2016 - 2027 (US$ Mn)
7. Competitive Landscape
8. Section
Companies Mentioned
A selection of companies mentioned in this report includes:
- Accuray, Inc.
- Avanos Medical, Inc.
- Boston Scientific Corporation
- Biosense Webster, Inc.
- Cosman Medical, Inc.
- Diros Technology, Inc.
- Kimberly-Clark Corporation
- NeuroTherm, Inc.
- St. Jude Medical, Inc.
- Stryker Corporation
